GB201411253D0 - Prodrug - Google Patents

Prodrug

Info

Publication number
GB201411253D0
GB201411253D0 GBGB1411253.6A GB201411253A GB201411253D0 GB 201411253 D0 GB201411253 D0 GB 201411253D0 GB 201411253 A GB201411253 A GB 201411253A GB 201411253 D0 GB201411253 D0 GB 201411253D0
Authority
GB
United Kingdom
Prior art keywords
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1411253.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nucana PLC
Original Assignee
Nucana Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nucana Biomed Ltd filed Critical Nucana Biomed Ltd
Priority to GBGB1411253.6A priority Critical patent/GB201411253D0/en
Publication of GB201411253D0 publication Critical patent/GB201411253D0/en
Priority to KR1020167033376A priority patent/KR102421929B1/en
Priority to SG11201608808TA priority patent/SG11201608808TA/en
Priority to MYPI2016002193A priority patent/MY183198A/en
Priority to MX2016015629A priority patent/MX2016015629A/en
Priority to PCT/GB2015/051857 priority patent/WO2015198058A1/en
Priority to ES15733498.8T priority patent/ES2655820T3/en
Priority to NZ765508A priority patent/NZ765508A/en
Priority to TW108132019A priority patent/TWI765176B/en
Priority to PT157334988T priority patent/PT3119794T/en
Priority to HUE15733498A priority patent/HUE036011T2/en
Priority to SG11201608809RA priority patent/SG11201608809RA/en
Priority to AU2015278900A priority patent/AU2015278900B2/en
Priority to HUE15733497A priority patent/HUE053240T2/en
Priority to MX2020004054A priority patent/MX2020004054A/en
Priority to TW109115415A priority patent/TWI758728B/en
Priority to RS20180003A priority patent/RS56752B1/en
Priority to TW104120671A priority patent/TWI695718B/en
Priority to DK15733497.0T priority patent/DK3160978T3/en
Priority to HRP20230584TT priority patent/HRP20230584T1/en
Priority to ES20187951T priority patent/ES2948660T3/en
Priority to DK15733498.8T priority patent/DK3119794T3/en
Priority to SI201531314T priority patent/SI3160978T1/en
Priority to CA2944966A priority patent/CA2944966C/en
Priority to NZ725205A priority patent/NZ725205A/en
Priority to MYPI2016002149A priority patent/MY186584A/en
Priority to US15/308,491 priority patent/US10662213B2/en
Priority to EP15733498.8A priority patent/EP3119794B1/en
Priority to JP2016574458A priority patent/JP6855248B2/en
Priority to KR1020227019095A priority patent/KR102563040B1/en
Priority to PL15733498T priority patent/PL3119794T3/en
Priority to JP2016573536A priority patent/JP6982957B2/en
Priority to HUE20187951A priority patent/HUE062474T2/en
Priority to KR1020227023672A priority patent/KR20220104270A/en
Priority to EP20187951.7A priority patent/EP3757112B1/en
Priority to RS20200953A priority patent/RS60968B1/en
Priority to MX2016015628A priority patent/MX2016015628A/en
Priority to EP15733497.0A priority patent/EP3160978B1/en
Priority to MX2021001140A priority patent/MX2021001140A/en
Priority to LTEP15733497.0T priority patent/LT3160978T/en
Priority to AU2015278899A priority patent/AU2015278899B2/en
Priority to EA201692312A priority patent/EA034890B1/en
Priority to EP17189351.4A priority patent/EP3269391A1/en
Priority to NZ725009A priority patent/NZ725009B2/en
Priority to PCT/GB2015/051858 priority patent/WO2015198059A1/en
Priority to US15/308,475 priority patent/US10117888B2/en
Priority to CN201911065790.0A priority patent/CN110882268A/en
Priority to BR112016025787-1A priority patent/BR112016025787B1/en
Priority to CN201580034740.XA priority patent/CN106459129B/en
Priority to EA201692422A priority patent/EA033046B1/en
Priority to PT157334970T priority patent/PT3160978T/en
Priority to ES15733497T priority patent/ES2811268T3/en
Priority to CA2945938A priority patent/CA2945938C/en
Priority to NO15733498A priority patent/NO3119794T3/no
Priority to SG10201907898SA priority patent/SG10201907898SA/en
Priority to CN201580034742.9A priority patent/CN106470672B/en
Priority to SI201530157T priority patent/SI3119794T1/en
Priority to TW104120487A priority patent/TWI674097B/en
Priority to MEP-2020-171A priority patent/ME03817B/en
Priority to KR1020167033632A priority patent/KR102407935B1/en
Priority to PL15733497T priority patent/PL3160978T3/en
Priority to CN202010140546.2A priority patent/CN111214480A/en
Priority to LTEP15733498.8T priority patent/LT3119794T/en
Priority to IL248345A priority patent/IL248345B/en
Priority to IL248642A priority patent/IL248642B/en
Priority to PH12016502552A priority patent/PH12016502552A1/en
Priority to CL2016003260A priority patent/CL2016003260A1/en
Priority to PH12016502553A priority patent/PH12016502553B1/en
Priority to CL2016003261A priority patent/CL2016003261A1/en
Priority to HK18103928.1A priority patent/HK1244437A1/en
Priority to HRP20180007TT priority patent/HRP20180007T1/en
Priority to CY20181100037T priority patent/CY1119772T1/en
Priority to US16/142,948 priority patent/US10786523B2/en
Priority to AU2019204557A priority patent/AU2019204557B2/en
Priority to AU2019216626A priority patent/AU2019216626B2/en
Priority to JP2020012388A priority patent/JP6970221B2/en
Priority to IL272724A priority patent/IL272724B/en
Priority to JP2020076384A priority patent/JP6970236B2/en
Priority to US16/865,527 priority patent/US11629164B2/en
Priority to IL276199A priority patent/IL276199B/en
Priority to CY20201100745T priority patent/CY1123389T1/en
Priority to HRP20201264TT priority patent/HRP20201264T1/en
Priority to US17/010,338 priority patent/US11040051B2/en
Priority to US17/324,835 priority patent/US11707477B2/en
Priority to JP2021176770A priority patent/JP7329025B2/en
Ceased legal-status Critical Current

Links

GBGB1411253.6A 2014-06-25 2014-06-25 Prodrug Ceased GB201411253D0 (en)

Priority Applications (85)

Application Number Priority Date Filing Date Title
GBGB1411253.6A GB201411253D0 (en) 2014-06-25 2014-06-25 Prodrug
KR1020167033376A KR102421929B1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
SG11201608808TA SG11201608808TA (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MYPI2016002193A MY183198A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MX2016015629A MX2016015629A (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug.
PCT/GB2015/051857 WO2015198058A1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
ES15733498.8T ES2655820T3 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine prodrug
NZ765508A NZ765508A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
TW108132019A TWI765176B (en) 2014-06-25 2015-06-25 Formulations of phosphate derivatives
PT157334988T PT3119794T (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
HUE15733498A HUE036011T2 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
SG11201608809RA SG11201608809RA (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
AU2015278900A AU2015278900B2 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
HUE15733497A HUE053240T2 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MX2020004054A MX2020004054A (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug.
TW109115415A TWI758728B (en) 2014-06-25 2015-06-25 Prodrug
RS20180003A RS56752B1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
TW104120671A TWI695718B (en) 2014-06-25 2015-06-25 Prodrug
DK15733497.0T DK3160978T3 (en) 2014-06-25 2015-06-25 GEMCITABIN PRODUCTS
HRP20230584TT HRP20230584T1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
ES20187951T ES2948660T3 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
DK15733498.8T DK3119794T3 (en) 2014-06-25 2015-06-25 FORMULA CONTAINING A GEMCITABIN PRODRUG
SI201531314T SI3160978T1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
CA2944966A CA2944966C (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
NZ725205A NZ725205A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MYPI2016002149A MY186584A (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
US15/308,491 US10662213B2 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
EP15733498.8A EP3119794B1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
JP2016574458A JP6855248B2 (en) 2014-06-25 2015-06-25 Formulation containing gemcitabine-prodrug
KR1020227019095A KR102563040B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
PL15733498T PL3119794T3 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
JP2016573536A JP6982957B2 (en) 2014-06-25 2015-06-25 Gemcitabine prodrug
HUE20187951A HUE062474T2 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
KR1020227023672A KR20220104270A (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
EP20187951.7A EP3757112B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
RS20200953A RS60968B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MX2016015628A MX2016015628A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs.
EP15733497.0A EP3160978B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
MX2021001140A MX2021001140A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs.
LTEP15733497.0T LT3160978T (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
AU2015278899A AU2015278899B2 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
EA201692312A EA034890B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
EP17189351.4A EP3269391A1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
NZ725009A NZ725009B2 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
PCT/GB2015/051858 WO2015198059A1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
US15/308,475 US10117888B2 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
CN201911065790.0A CN110882268A (en) 2014-06-25 2015-06-25 Formulations comprising gemcitabine prodrugs
BR112016025787-1A BR112016025787B1 (en) 2014-06-25 2015-06-25 PHARMACEUTICAL FORMULATION COMPRISING GENCITABIN-[PHENYL-(BENZOXY-L-ALANINYL)]-PHOSPHATE, ITS USE IN THE TREATMENT OF CANCER, METHOD OF PREPARATION AND KIT COMPRISING THE SAME
CN201580034740.XA CN106459129B (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
EA201692422A EA033046B1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
PT157334970T PT3160978T (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
ES15733497T ES2811268T3 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
CA2945938A CA2945938C (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
NO15733498A NO3119794T3 (en) 2014-06-25 2015-06-25
SG10201907898SA SG10201907898SA (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
CN201580034742.9A CN106470672B (en) 2014-06-25 2015-06-25 Preparation including gemcitabine prodrug
SI201530157T SI3119794T1 (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
TW104120487A TWI674097B (en) 2014-06-25 2015-06-25 Formulations of phosphate derivatives
MEP-2020-171A ME03817B (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
KR1020167033632A KR102407935B1 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
PL15733497T PL3160978T3 (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
CN202010140546.2A CN111214480A (en) 2014-06-25 2015-06-25 Gemcitabine prodrugs
LTEP15733498.8T LT3119794T (en) 2014-06-25 2015-06-25 Formulation comprising a gemcitabine-prodrug
IL248345A IL248345B (en) 2014-06-25 2016-10-13 Formulation comprising a gemcitabine-prodrug
IL248642A IL248642B (en) 2014-06-25 2016-10-31 Gemcitabine prodrugs
PH12016502552A PH12016502552A1 (en) 2014-06-25 2016-12-20 Formulation comprising a gemcitabine-prodrug
CL2016003260A CL2016003260A1 (en) 2014-06-25 2016-12-20 Gemcitabine prodrugs
PH12016502553A PH12016502553B1 (en) 2014-06-25 2016-12-20 Gemcitabine prodrugs
CL2016003261A CL2016003261A1 (en) 2014-06-25 2016-12-20 Formulation comprising a gemcitabine prodrug
HK18103928.1A HK1244437A1 (en) 2014-06-25 2017-02-04 Formulation comprising a gemcitabine-prodrug
HRP20180007TT HRP20180007T1 (en) 2014-06-25 2018-01-03 Formulation comprising a gemcitabine-prodrug
CY20181100037T CY1119772T1 (en) 2014-06-25 2018-01-11 CONSTRUCTION CONTAINED BY GEMSITABIN PRODUCT
US16/142,948 US10786523B2 (en) 2014-06-25 2018-09-26 Formulation comprising a gemcitabine-prodrug
AU2019204557A AU2019204557B2 (en) 2014-06-25 2019-06-27 Formulation comprising a gemcitabine-prodrug
AU2019216626A AU2019216626B2 (en) 2014-06-25 2019-08-13 Gemcitabine prodrugs
JP2020012388A JP6970221B2 (en) 2014-06-25 2020-01-29 Gemcitabine-formation containing prodrug
IL272724A IL272724B (en) 2014-06-25 2020-02-17 Gemcitabine prodrug for use in treating cancer
JP2020076384A JP6970236B2 (en) 2014-06-25 2020-04-22 Gemcitabine prodrug
US16/865,527 US11629164B2 (en) 2014-06-25 2020-05-04 Gemcitabine prodrugs
IL276199A IL276199B (en) 2014-06-25 2020-07-21 Formulation comprising a gemcitabine-prodrug
CY20201100745T CY1123389T1 (en) 2014-06-25 2020-08-10 GEMCITABINE PRODUCTS
HRP20201264TT HRP20201264T1 (en) 2014-06-25 2020-08-11 Gemcitabine prodrugs
US17/010,338 US11040051B2 (en) 2014-06-25 2020-09-02 Formulation comprising a gemcitabine-prodrug
US17/324,835 US11707477B2 (en) 2014-06-25 2021-05-19 Formulation comprising a gemcitabine-prodrug
JP2021176770A JP7329025B2 (en) 2014-06-25 2021-10-28 Formulations containing gemcitabine-prodrugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1411253.6A GB201411253D0 (en) 2014-06-25 2014-06-25 Prodrug

Publications (1)

Publication Number Publication Date
GB201411253D0 true GB201411253D0 (en) 2014-08-06

Family

ID=51410067

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1411253.6A Ceased GB201411253D0 (en) 2014-06-25 2014-06-25 Prodrug

Country Status (1)

Country Link
GB (1) GB201411253D0 (en)

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3236972T3 (en) Antivirale N4-hydroxycytidin-derivativer
DK3373003T3 (en) Urinteststrimmel
AU361515S (en) Dishrack
AU362944S (en) Lapboard
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
RS59406B1 (en) Improved biobinder
DK3234061T3 (en) Nano-inhibitorer
DK3194944T3 (en) Tomografiapparat
GB201521215D0 (en) Prodrug
DK3145380T3 (en) Toiletventilationssystem
GB201411253D0 (en) Prodrug
AU5598P (en) Lanidaho Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5585P (en) Lanutah Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5287P (en) FLOMANPIW Mandevilla sanderi
AU5288P (en) FLOMANTOG Mandevilla sanderi
AU5285P (en) FLOMANRER Mandevilla sanderi

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)